As payers and consumers place increasing emphasis on positive outcomes for patients' health, organizations are developing their health outcomes data generation and utilization skills. The Medical Affairs (MA) function plays a vital role in health outcomes (HO) information exchange between biopharmaceutical companies and key external stakeholders.
Development of strong HO capabilities within MA organizations requires increase in MA’s involvement with HO groups, development of field-based HO capabilities, customization of HO data according to stakeholders, and building real world data capabilities to generate and utilize HO information.
Best Practices, LLC undertook a study to help companies focused on oncology therapies find better ways to develop successful Health Outcomes groups. This research delivers current data and best practices from Medical Affairs leaders with an oncology focus at top biopharmaceutical companies.